Morris, P., Garber, G., Laterre, P.-F., & Levy, H. (2001). Drotrecogin alfa (activated) reduced the number of deaths attributed to cardiovascular and pulmonary organ failure in patients with severe sepsis. Critical Care Medicine, 29(12), A11-A11. (Original work published 2001)